Risks and Returns of Charles River Laboratories International Inc. (CRL) Stock

Guggenheim raised the price target for the Charles River Laboratories International Inc. (NYSE:CRL) stock from “a Buy” to “a Neutral”. The rating was released on February 15, 2024, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $225. The stock was upgraded […]

Charles River Laboratories International Inc. (CRL) Stock Is Emerging from the Clouds

Guggenheim raised the price target for the Charles River Laboratories International Inc. (NYSE:CRL) stock from “a Buy” to “a Neutral”. The rating was released on February 15, 2024, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $225. The stock was upgraded […]